A team at UCL Great Ormond Street Institute of Child Health and University College London working with the Royal Brompton Hospital have identified a new gene which causes the lung condition Primary Ciliary Dyskinesia (PCD). Working with researchers from around Europe including hospitals in Italy, Switzerland and France, the team have shown that the condition can be 'X-linked' meaning it is passed from mothers to their sons.
Scientists have discovered the gene essential for chemically reprogramming human amniotic stem cells into a more versatile state similar to embryonic stem cells, in research led by UCL and Heinrich Heine University.
Children’s medical research charity Sparks has announced today (Monday 23rd January 2017) that it will be joining Great Ormond Street Hospital Children’s Charity in a partnership which will result in an increase in funding for pioneering and life-changing child health research.
Three UCL international collaborations are among the first to receive Global Challenges Research Fund (GCRF) awards, in recognition of their world-leading research partnerships improving health in low and middle income countries.
Cells from pregnant women could prevent fractures by nearly 80 per cent for millions with fragile bones
Injecting cells from pregnant women could have a life-changing effect on the millions who are living with osteoporosis and brittle bone disease according to researchers at the UCL GOS Institute of Child Health, the research partner of Great Ormond Street Hospital and The UCL Institute for Women’s Health. These cells could also be useful for strengthening the fragile bones of astronauts during their stay for long periods in space.
Researchers from the UCL GOS Institute of Child Health have discovered a new gene change that identifies a type of the movement disorder, muscle dystonia. This new discovery will allow doctors to more easily identify patients who can benefit from treatment so effective that it can restore the ability to walk.
Children with severe epilepsy who do not respond to traditional drugs could be treated with vitamin B6, after the discovery of a new gene by UCL Great Ormond Street Institute of Child Health (ICH) and its clinical partner Great Ormond Street Hospital (GOSH).
€7 million EU Horizon2020 Award for ZIKAction: Preparedness, research and action network on maternal-paediatric axis of ZIKV infection in Latin America and the Caribbean.
The prospect of widespread access to a life-changing drug for children with a rare muscular disorder is a step closer today after the United States Food and Drug Administration (FDA) granted accelerated approval for a new medication.